142 related articles for article (PubMed ID: 17241662)
1. Indirect immunofluorescent assay for antinuclear antibodies on McCoy-Plovdiv serum-free cell line substrate.
Zagorov MY; Draganov MM; Alimanska SA; Staykova ND; Stefanov RS; Trayancheva M; Kuzmanova SI; Murdjeva MA
Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):153-62. PubMed ID: 17241662
[TBL] [Abstract][Full Text] [Related]
2. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
Chopra A; Anuradha V; Edmonds J
J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic specificities and sensitivities of anti dsDNA, anti membrane DNA and anti nucleosomes autoantibodies.
Servais G; Daens S; Guillaume MP; Cumps J; Duchateau J; Peretz A
Scand J Clin Lab Invest Suppl; 2001; 235():61-7. PubMed ID: 11712694
[TBL] [Abstract][Full Text] [Related]
4. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate].
Lüthke K; Conrad K; Frank KH
Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of antinuclear antibodies.
Meryhew NL; Messner RP; Tan EM
J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697
[TBL] [Abstract][Full Text] [Related]
6. Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis.
Fawcett PT; Rose CD; Gibney KM; Emerich MJ; Athreya BH; Doughty RA
J Rheumatol; 1999 Aug; 26(8):1822-6. PubMed ID: 10451083
[TBL] [Abstract][Full Text] [Related]
7. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
[TBL] [Abstract][Full Text] [Related]
8. Problems in ANA test interpretation: a comparison of two substrates.
Rippey JH; Carter S; Hood P; Carter JB
Diagn Immunol; 1985; 3(1):43-6. PubMed ID: 3873318
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibody testing. A study of clinical utility.
Slater CA; Davis RB; Shmerling RH
Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of combined antinuclear and anticytoplasmic antibodies detected by immunofluorescence.
Lee TK; Rothberger H
Chin Med J (Engl); 1989 Dec; 102(12):911-5. PubMed ID: 2517735
[TBL] [Abstract][Full Text] [Related]
11. Comparison of substrates for the detection of antinuclear antibodies in normals and in patients with connective tissue and other diseases.
Lipscomb MF; Cope LD; Stephens GL; Deng JS; Gilliam JN
Diagn Immunol; 1984; 2(3):181-7. PubMed ID: 6388982
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
[TBL] [Abstract][Full Text] [Related]
13. [Serological diagnosis of systemic connective tissue inflammation; a new immunofluorescence method for demonstrating antinuclear antibodies].
Scagliusi P; Laghezza D; Ferrari G; Fasiello V; De Lucia M
Minerva Med; 1981 Jan; 72(2):81-90. PubMed ID: 7007926
[TBL] [Abstract][Full Text] [Related]
14. Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children.
Kasapçopur O; Ozbakir F; Arisoy N; Ingöl H; Yazici H; Ozdoğan H
Turk J Pediatr; 1999; 41(1):67-71. PubMed ID: 10770678
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the methods used for the detection of antinuclear antibodies].
Berkem R; Gümüş T; Karakoç E; Acar N
Mikrobiyol Bul; 2003; 37(2-3):171-8. PubMed ID: 14593900
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay.
Bayer PM; Bauerfeind S; Bienvenu J; Fabien N; Frei PC; Gilburd B; Heide KG; Hoier-Madsen M; Meroni PL; Monier JC; Monneret G; Panzeri P; Shoenfeld Y; Spertini F; Wiik A
J Autoimmun; 1999 Aug; 13(1):89-93. PubMed ID: 10441172
[TBL] [Abstract][Full Text] [Related]
17. [A comparative study of the ELISA and IF methods for antinuclear antibody test].
Shiba N; Note R; Hayashi S; Ozawa T; Niiya K; Sakuragawa N
Rinsho Byori; 1997 Feb; 45(2):175-8. PubMed ID: 9121002
[TBL] [Abstract][Full Text] [Related]
18. Nuclear matrix antibodies in rheumatic diseases.
Kurki P; Virtanen I; Lehto VP; Helve T
J Rheumatol; 1985 Apr; 12(2):253-6. PubMed ID: 3897532
[TBL] [Abstract][Full Text] [Related]
19. Studies of antinuclear antibodies in rheumatoid arthritis.
Garcia-de la Torre I; Miranda-Mendez L
J Rheumatol; 1982; 9(4):603-6. PubMed ID: 6182293
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value for rheumatoid arthritis of antiperinuclear factor at the 1:100 threshold. Study of 600 patients and meta-analysis of the literature.
Berthelot JM; Garnier P; Glémarec J; Flipo RM
Rev Rhum Engl Ed; 1998 Jan; 65(1):9-14. PubMed ID: 9523380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
